Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease
Tubulointerstitial fibrosis plays an important role in the progression of diabetic kidney disease (DKD). Sacubitril/valsartan (Sac/Val) exerts a robust beneficial effect in DKD. However, the potential function...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Xing-Jian Zhang, Cong-Cong Liu, Zuo-Lin Li, Lin Ding, Yan Zhou, Dong-Jie Zhang, Yao Zhang, Shu-Ting Hou and Rui-Xia Ma Tags: Research Source Type: research
More News: Diabetes | Diovan | Endocrinology | Metabolic Syndrome | Mitochondrial Disease | Urology & Nephrology